Autosomal recessive Adams-Oliver syndrome was diagnosed in three remotely related Bedouin consanguineous families. Genome-wide linkage analysis ruled out association with known Adams-Oliver syndrome genes, identifying a singlehomozygosity B1.8-Mb novel locus common to affected individuals (LOD score 3.37). Whole-exome sequencing followed by Sanger sequencing identified only a single mutation within this locus, shared by all affected individuals and found in patients from five additional apparently unrelated Bedouin families: a 1-bp deletion mutation in a predicted alternative splice variant of EOGT, leading to a putative truncated protein. RT-PCR demonstrated that the EOGT-predicted alternative splice variant is ubiquitously expressed. EOGT encodes EGF-domain-specific O-linked N-acetylglucosamine transferase, responsible for extracellular O-GlcNAcylation of epidermal growth factor-like domain-containing proteins, and is essential for epithelial cell-matrix interactions. F-actin staining in diseased fibroblasts showed apparently intact cell cytoskeleton and morphology, suggesting the EOGT mutation acts not through perturbation of cytoskeleton but through other mechanisms yet to be elucidated.
INTRODUCTION
Adams-Oliver syndrome (AOS; MIM 100300) is a multiple congenital anomaly syndrome characterized by vertex scalp defects (aplasia cutis congenita; ACC), with terminal transverse limb defects (TTLD). 1 Limb defects range from nail dystrophy and syndactyly to asymmetric shortening of hands and feet, to absence of digital extremities. 2 Deformities of the skull are found in some cases. Additional clinical manifestations can include congenital cardiac malformations, vascular defects, and neurological abnormalities. 2 AOS has been described in both autosomal dominant and recessive modes of inheritance. 2 Recent identification of AOS-causing dominant mutations in ARHGAP31 (MIM 610911) 3 and recessive mutations in DOCK6 (MIM 614194) 4 confirms both modes of inheritance and highlights Cdc42/Rac1 regulation of actin cytoskeleton during early human development. AOS can be caused also by dominant mutations in RBPJ (MIM 147183), a transcriptional regulator of the NOTCH signaling pathway, further demonstrating the genetic heterogeneity of the phenotype. 5 As some features of AOS are consistent with vascular disruption pathogenesis, 2 it is yet unclear how disrupted Cdc42/Rac1 or NOTCH signaling intersects in the pathogenesis of AOS. Identification of additional genes implicated in AOS might elucidate common molecular pathways leading to this disease.
MATERIALS AND METHODS Patients
We studied eight affected individuals of three remotely related consanguineous families of the same Bedouin tribe ( Figure 1a ) and seven individuals of five additional Bedouin families of other tribes, originated from the same clan ( Figure 1b) . Following Soroka Medical Center IRB approval and informed consent, DNA samples were obtained from all available affected family members, their siblings, and obligatory carrier parents.
Linkage analysis
Genome-wide linkage analysis was done using Affymetrix GeneChip Human Mapping 250K Array Nsp (Affymetrix, Santa Clara, CA, USA) as previously described, 6 testing one affected individual of each family (P1-IV:6, P2-IV:6, and P3-IV:1). Genotype data were analyzed using Homozygosity Mapper (http://www.homozygositymapper.org/), and multipoint LOD score was calculated as previously described, 6 using SUPERLINK (http:// cbl-hap.cs.technion.ac.il/superlink-snp/). Four informative markers were used for the analysis: chr3:68907579-68907912, D3S1296, D3S1566, and D3S2454.
Whole-exome sequencing
Whole-exome sequencing of individual IV:6 of pedigree P1 (Figure 1a ) was performed using HiSeq2000 (Illumina, San Diego, CA, USA) and analyzed as previously described. 6 All uncovered regions in the disease-associated interval were PCR amplified and Sanger sequenced using the ABI PRISM 3730 DNA Analyser (Applied Biosystems, Foster city, CA, USA).
Mutation detection-restriction analysis
MnlI restriction analysis gave differential cleavage products for the EOGT wild-type and mutant sequences: 223 bp in the wild-type versus 188 bp and 34 bp fragments in the mutant. PCR amplification primers were as follows: forward 5 0 -AAGCAATGCAAAATGGAGATT-3 0 ; reverse 5 0 -CACAA AAACATGGTCTCCTGA-3 0 .
RT-PCR
EOGT expression was determined using PCR amplification of cDNA from various human tissues and cells. The primer sets used flank exons common to both the 15 and the 18 exon splice variants of EOGT: forward EOGT in Adams-Oliver syndrome I Cohen et al
F-Actin staining
Fibroblasts were stained for F-actin using phalloidin (Alexa Fluor 546; Invitrogen Corporation, Carlsbad, CA, USA). Cells were stained and visualized using confocal microscopy as previously described. 7 
RESULTS
All studied patients were diagnosed with autosomal recessive AOS. Apart from the aplasia cutis, the phenotype of all patients was very minimal (Table 1 and Figure 1c -f): all had scalp skin defects to different extents and limb defects ranging from minimal nail deformities to syndactyly mainly of toes. Some had skull defects at the vertex and dilated scalp veins. No further anomalies were found. Genome-wide linkage analysis of the related families P1, P2, and P3 ( Figure 1a ) followed by homozygosity mapping identified a single 1.8-Mb novel locus between SNPs rs1602197 and rs4974301 on chromosome 3p14.1-13 (Chr3:68 831 371-70 639 463; GRCh37/hg19) that was common to all tested patients (Figure 2a) . Genotyping of the three pedigrees combined (Figure 1a ) yielded a maximum LOD score of 3.37. All affected individuals shared a common homozygous haplotype between markers chr3:68907579-68907912 and D3S2454, supporting a common ancestral origin for this locus. Whole-exome sequencing of an affected individual fully covered the 1.8-Mb interval, except for segments of EOGT (MIM 614789). Sanger sequencing of those segments identified a single homozygous mutation (Figure 2b ): c.1074delA (p. Gly359Aspfs*28) in exon 13 of a predicted alternative splice variant of EOGT (RefSeq NM_173654.1; ENST00000383701.3), leading to a frameshift and premature stop codon. This predicted alternative splice variant is composed of 18 exons, similar to characterized EOGT orthologs in the mouse and drosophila. 8 The mutation was not found in any SNP or mutation database. Restriction analysis using MnlI demonstrated that the mutation was common to all affected individuals in the three pedigrees, and that all obligatory carriers in those pedigrees were indeed heterozygous for the mutation (Figure 1a) . None of the 100 nonrelated Israeli Bedouins controls of other clans carried the mutation. Screening of additional AOS families with no known relation to the cohort studied yet of the same clan (Figure 1b) identified five additional unrelated consanguineous Bedouin AOS families with the EOGT c.1074delA mutation.
PCR amplification of cDNA, from various human tissues and cells, showed a single product that was ubiquitously expressed (Figure 2c ) and represents the 18-exon splice variant (ENST00000383701.3), which has no representation in RefSeq. F-actin staining in diseased fibroblasts showed typical normal appearance and well-organized actin cytoskeleton filaments, similar to normal control fibroblasts, with no unusual rounded cell shapes or the perturbed actin cytoskeleton and lamellipodia (Figure 2d) .
DISCUSSION
This study, together with a parallel independent study by Shaheen et al., 9 which identified three EOGT mutations in different Arab families, defines EOGT as a novel Adams-Oliver syndrome gene. Both studies identified a common c.1074delA founder mutation in the Arab world. It should be noted that the ancestors of many of the Bedouins of southern Israel migrated from the Arabian Peninsula before the spread of the Islam around 700 AC, forming several large clans (including the clan in this study) and carry similar founder mutations. 6 The c.1074delA mutation was not found in 100 controls of Bedouins of various tribes of non-related clans from southern Israel, suggesting that it is present in only a specific cohort within that community.
The ubiquitous expression of the 18-exon splice variant (ENST00000383701.3) in various human tissues (Figure 2c ) provides supporting evidence that the c.1074delA mutation is expected to have a significant effect on the encoded protein. In line with the AdamsOliver syndrome phenotype, Eogt mRNA is highly expressed in the developing limb buds of mice, showing a digit condensation pattern in the limbs by E12.5. 9 EOGT encodes EGF-domain-specific O-linked N-acetylglucosamine (O-GlcNAc) transferase, which is responsible for extracellular O-GlcNAcylation of epidermal growth factor-like domain-containing proteins. 8 O-GlcNAc modification is a unique Table 1 dynamic post-transcriptional modification that regulates a variety of cellular processes including intracellular signaling, transcription, and protein stability. 10 Drosophila Eogt mutants display defects in the apical extracellular matrix (aECM), including separation of the epidermis from the chitin layers and wing blistering. 10 Among Eogt targets are Notch and Dumpy, a membrane-anchored extracellular protein required for epithelial cell-matrix interaction. Eogt drosophila mutants display apparently intact Notch signaling, despite Notch not being O-GlcNAc modified. However, Eogt is essential for Dumpydependent epithelial cell-matrix interactions. 10 This suggests that 
